Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739323 · ClinicalTrials.gov registry record

Impaired Wound Healing in Diabetic Foot Ulceration

A clinical trial of Healthy Volunteers and Diabetes Mellitus, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
137
Enrollment target
1
Study location

NCT00739323: Completed study of Healthy Volunteers and Diabetes Mellitus, sponsored by Beth Israel Deaconess Medical Center.

NCT00739323 is a study of Healthy Volunteers and Diabetes Mellitus that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 137 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739323, a study of Healthy Volunteers and Diabetes Mellitus, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
137 participants
Enrollment target
1
Study location

Study Summary

An observational study to gather information about people who may have certain abnormalities in skin microcirculation and muscle metabolism and to determine whether these abnormalities affect wound healing. The study also examines the association of a specific type of cell with the rate of wound healing.

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 137 participants
Start Date 2006-12
Est. Completion 2012-09

What the finished NCT00739323 record still lists

NCT00739323 is an observational study that tracks outcomes without assigning an intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 0 interventions.

NCT00739323 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00739323 about?

NCT00739323 is a clinical study titled "Impaired Wound Healing in Diabetic Foot Ulceration". An observational study to gather information about people who may have certain abnormalities in skin microcirculation and muscle metabolism and to determine whether these abnormalities affect wound healing. The study also examines the association of a specific type of cell with the rate of wound hea...

What is the current status of trial NCT00739323?

This trial is currently completed. The enrollment target is 137 participants. The study started on 2006-12. Estimated completion is 2012-09.

What conditions does trial NCT00739323 study?

This clinical trial studies the following conditions: Healthy Volunteers, Diabetes Mellitus.

Who is sponsoring clinical trial NCT00739323?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00739323 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00739323's enrollment target sits among peer trials

137 61st of 283 higher than 223 of 283 other Healthy Volunteers trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05091424 · 137 participants · Phase 1

    A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  • NCT05655182 · 137 participants · Phase 1

    A Study of BLB-201 RSV Vaccine in Infants and Children

  • NCT06571669 · 137 participants · NA

    BOOM-IBD2 Pivotal Clinical Trial

  • NCT06644768 · 137 participants · Phase 1

    A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00739323, the US trial registry maintained by the National Library of Medicine. NCT00739323 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.